K
Karynsa Cetin
Researcher at Amgen
Publications - 38
Citations - 1210
Karynsa Cetin is an academic researcher from Amgen. The author has contributed to research in topics: Population & Prostate cancer. The author has an hindex of 12, co-authored 38 publications receiving 1003 citations.
Papers
More filters
Journal ArticleDOI
Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006.
Deirdre Cronin-Fenton,F. Søndergaard,L. Pedersen,Jon P. Fryzek,Karynsa Cetin,John F. Acquavella,John A. Baron,Henrik Toft Sørensen +7 more
TL;DR: Risk of VTE is higher among cancer patients than in the general population and among patients receiving chemotherapy, either alone or in combination treatments, while adjusting for comorbidity.
Journal ArticleDOI
Estimated number of prevalent cases of metastatic bone disease in the US adult population.
Shuling Li,Yi Peng,Eric D. Weinhandl,Anne H. Blaes,Karynsa Cetin,Victoria M. Chia,Scott Stryker,Joseph J Pinzone,John F. Acquavella,Thomas J. Arneson +9 more
TL;DR: The findings suggest that approximately 280,000 US adults were living with metastatic bone disease on December 31, 2008, which likely underestimates the true frequency; not all cases of metastaticBone disease are diagnosed, and some diagnosed cases might lack documentation in claims data.
Journal ArticleDOI
Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and end results program
TL;DR: A poor prognosis across histologic subtypes in stage IV NSCLC patients is demonstrated but differences in both absolute survival and the relative importance of select prognostic factors by histologic subclassification are highlighted.
Journal ArticleDOI
Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study.
Karynsa Cetin,Christian Fynbo Christiansen,Jacob Jacobsen,Mette Nørgaard,Henrik Toft Sørensen +4 more
TL;DR: Bone metastases predict a poor prognosis in lung cancer patients and to quantify their impact on mortality, a nationwide cohort study of patients diagnosed with lung cancer between 1999 and 2010 in Denmark is conducted.
Journal ArticleDOI
The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975–2004)
TL;DR: The first reliable population-based estimates of incidence, patient demographics, treatment course and survival for malignancy in GCT of bone in the United States from 1975-2004 are offered and suggest that age and stage at diagnosis are strongly associated with long-term survival.